22752860Nerandzic MM, Mullane K, Miller MA, Babakhani F, Donskey CJClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaAminoglycosides; Candida; Clostridioides difficile; Clostridium Infections; Enterococcus; VancomycinAdult; Aged; Anti-Bacterial Agents; Canada; Double-Blind Method; Drug Resistance, Bacterial; Feces; Female; Fidaxomicin; Humans; Incidence; Limit of Detection; Male; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome; United StatesReduced acquisition and overgrowth of vancomycin-resistant enterococci and Candida species in patients treated with fidaxomicin versus vancomycin for Clostridium difficile infection. Clin Infect Dis. 2012 Aug; 55 Suppl 2:S121-6.Clin Infect Dis2012-08-01T00:00:002012Reduced acquisition and overgrowth of vancomycin-resistant enterococci and Candida species in patients treated with fidaxomicin versus vancomycin for Clostridium difficile infection.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000617Chemicals & Drugs14320.97934AminoglycosidesD000368Living Beings1341183530.294764AgedD000328Living Beings1578255770.254432AdultD002175Living Beings14170.98169CandidaD003015Disorders441250.830502Clostridium InfectionsD004311Procedures33818220.708936Double-Blind MethodMedicine-Infectious DiseasesD005243Anatomy1183160.860891FecesD008875Concepts & IdeasLiving Beings1473249570.258811Middle AgedD008826Procedures681420.945408Microbial Sensitivity TestsD005260Physiology1992444050.191167FemaleD006801Living Beings2262862810.130052HumansAuthorship 488622D015994Concepts & Ideas56115680.709073IncidenceD014481Geographic Areas102566370.406601United StatesD008297Physiology1931408600.201617MaleD016896Concepts & Ideas101179490.402389Treatment Outcome0.1114520.1114521authors10.2521has subject areaD016983Living Beings20350.969155EnterococcusD024881Physiology43710.948001Drug Resistance, BacterialD014640Chemicals & Drugs44720.944192VancomycinD057230Concepts & Ideas14200.992364Limit of DetectionD000900Chemicals & Drugs3287390.670756Anti-Bacterial AgentsD002170Geographic Areas1272040.940856CanadaUniversity of ChicagoKathleenMullaneKathleen Mullane41.78927490000000-87.60125000000000635Mullane, KathleenClinical Professortrue1Clinical ProfessorClinical Professor